POMALIDOMIDE
Generic: POMALIDOMIDE
Natco Pharma LimitedManufacturer
ORALRoute
POMALIDOMIDEActive Substance
2020-10-30Original Approval
POMALIDOMIDE is FDA application ANDA210111, sponsored by BRECKENRIDGE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PLASMA CELL MYELOMA
2,339 reports
2
NEUTROPENIA
1,539 reports
3
PNEUMONIA
1,107 reports
4
OFF LABEL USE
1,081 reports
5
DEATH
913 reports
6
THROMBOCYTOPENIA
854 reports
7
ANAEMIA
794 reports
8
DRUG INEFFECTIVE
626 reports
9
FATIGUE
538 reports
10
PYREXIA
532 reports